Showing results (1041-1050 of 1,244) with videos related to
Sort By:
Pageof 125
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptorsAngela Coxon, Tammy Bush, Douglas Saffran, et al.Plastic and Reconstructive Surgery. Global Open|November 11, 2020
Cortical Thickness in Crouzon-Pfeiffer Syndrome: Findings in Relation to Primary Cranial Vault ExpansionAlexander T Wilson, Catherine A de Planque, Sumin S Yang, et al.Critical Care Medicine|November 21, 2002
Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatricsEmily L Dobyns, Nick G Anas, James D Fortenberry, et al.Vaccine|January 23, 2026
Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trialsJoanne M Langley, Manish Sadarangani, Christian Ockenhouse, et al.International Journal of Environmental Research and Public Health|March 25, 2022
A Qualitative Study Exploring Access to Mental Health and Substance Use Support among Individuals Experiencing Homelessness during COVID-19Emma A Adams, Jeff Parker, Tony Jablonski, et al.Veterinary Microbiology|December 25, 2010
First morphological characterization of 'Candidatus Mycoplasma turicensis' using electron microscopyBarbara Willi, Kristina Museux, Marilisa Novacco, et al.Microbes and Infection|February 18, 2006
Effect of chronic feline immunodeficiency infection, and efficacy of marbofloxacin treatment, on 'Candidatus Mycoplasma haemominutum' infectionSéverine Tasker, Sarah M A Caney, Michael J Day, et al.Veterinary Microbiology|August 1, 2006
Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infectionSéverine Tasker, Sarah M A Caney, Michael J Day, et al.The Journal of Infectious Diseases|February 18, 2011
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialAnuradha Ganesan, Nancy Crum-Cianflone, Jeanette Higgins, et al.Sexually Transmitted Diseases|September 16, 2003
Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virusNancy F Crum, Mark R Wallace, Kevin Stephan, et al.Pageof 125